Cancer Drug Developer GeneSegues Therapeutics Names Laura Morris Brod as CEO
Company Positioned to Accelerate Growth PlansGeneSegues Therapeutics, a leader in innovative RNAi and DNA therapeutics for cancer and infectious diseases, today announced the addition of its new CEO. “We’re very excited to have Laura Brod…


